PALS

2026 LuCIN Community Meeting Focuses on Integrating Clinical Trials into Day-to-Day Clinical Care 

What if clinical trials were not a final option, but a routine part of lupus care?   That question took center stage at the 2026 Lupus Clinical Investigators Network (LuCIN) Community Meeting, where people living with lupus, researchers, clinicians, and industry leaders came together to reshape the future of treatment. LuCIN Investigators (left) and Coordinators join onsite for meaningful 2026 LuCIN Community Meeting Focuses on Integrating Clinical Trials into Day-to-Day Clinical Care 

Lupus Therapeutics, the Clinical Affiliate of the Lupus Research Alliance, Broadens Proven Peer-to-Peer Program in Clinical Trials

Today, Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance, announced the expansion of its proven peer-to-peer clinical research education program – Patient Advocates for Lupus Studies (PALS) – making it available to hundreds of individuals living with lupus across North America. The expansion builds on the program’s success to date and aims to Lupus Therapeutics, the Clinical Affiliate of the Lupus Research Alliance, Broadens Proven Peer-to-Peer Program in Clinical Trials